These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 7033097)

  • 1. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
    Butkus A; Shirey EK; Schumacher OP
    Artery; 1982; 11(3):238-51. PubMed ID: 7184495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
    Gerrard JM; Stuart MJ; Rao GH; Steffes MW; Mauer SM; Brown DM; White JG
    J Lab Clin Med; 1980 Jun; 95(6):950-8. PubMed ID: 6445927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
    Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
    J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 15. Indirect evidence of impairment of platelet desaturase enzymes in diabetes mellitus.
    Jones DB; Carter RD; Mann JI
    Horm Metab Res; 1986 May; 18(5):341-4. PubMed ID: 3013745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
    Vericel E; Lagarde M
    Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.